FindTrial
Sign In

Comparing Quality of Life: Psoriasis Patients vs. General Population - Insights from a Cross-Sectional Study

Assessing and comparing the quality of life on individuals affected by Psoriasis versus normal patient-A Cross-Sectional Study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/067585
Enrollment
25
Registered
2024-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: NIL: NA

Sponsors

Datta Meghe Institude of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Psoriasis Group: Individuals of with a confirmed diagnosis of psoriasis. Control Group: Individuals without a history of psoriasis and individuals with a history of fever.

Exclusion criteria

Exclusion criteria: Above 65. General population. Individuals with other chronic dermatological or systemic conditions affecting QoL.

Design outcomes

Primary

MeasureTime frame
Change in DLQI scores of patients with psoriasis and fever will be assessed.Timepoint: 1 Year—

Secondary

MeasureTime frame
Response rates will be compared between the psoriasis patient and fever patient treatment groups.Timepoint: 1 Year—

Countries

India

Contacts

Public ContactMr Gaurav Mude

Datta Meghe Institute of Higher Education and Research

gauravpharmacy@dmiher.edu.in8007095656

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026